Skip to main content
Top
Published in: BMC Clinical Pathology 1/2017

Open Access 01-12-2017 | Research article

Cerebrospinal fluid pleocytosis level as a diagnostic predictor? A cross-sectional study

Authors: Anne Ahrens Østergaard, Thomas Vognbjerg Sydenham, Mads Nybo, Åse Bengård Andersen

Published in: BMC Clinical Pathology | Issue 1/2017

Login to get access

Abstract

Background

Lumbar puncture with quantification of leukocytes and differential count of cellular subsets in the cerebrospinal fluid is a standard procedure in cases of suspected neuroinfectious conditions. However, a number of non-infectious causes may result in a low leukocyte number (0–1000 cells/ml). We wanted to assess the diagnostic diversity of unselected adult patients with pleocytosis in the cerebrospinal fluid.

Methods

The study is based on data from cerebrospinal fluid (CSF) analyses of all adult patients (15 years or older) admitted to a large university hospital in Denmark during a two-year period (2008–2009). Data from the local patient administrative system supplied with data from patient charts were combined with laboratory data.

Results

A total of 5390 cerebrospinal fluid samples from 3290 patients were included. Pleocytosis >5 leucocytes/μl was found in samples from 262 patients of which 106 (40.5%) were caused by infection of the central nervous system (CNS), 20 (7.6%) by infection outside CNS, 79 (30.2%) due to non-infectious neurological diseases, 23 (8.8%) by malignancy, and 34 (13.0%) caused by other conditions. Significantly higher mean CSF leukocytes was found in patients suffering from CNS infection (mean 1135 cells/μl, p-value <0.0001).

Conclusions

CNS infection, non-infectious neurological disease, malignancy, and infection outside CNS can cause pleocytosis of the cerebrospinal fluid. Leukocyte counts above 100/μl is mainly caused by CNS infection, whereas the number of differential diagnoses is higher if the CSF leukocyte counts is below 50/μl. These conditions are most commonly caused by non-infectious neurological diseases including seizures.
Appendix
Available only for authorised users
Literature
1.
go back to reference Michael BD, Sidhu M, Stoeter D, Roberts M, Beeching NJ, Bonington A, Hart IJ, Kneen R, Miller A, Solomon T. Acute central nervous system infections in adults--a retrospective cohort study in the NHS north west region. QJM. 2010;103(10):749–58.CrossRefPubMed Michael BD, Sidhu M, Stoeter D, Roberts M, Beeching NJ, Bonington A, Hart IJ, Kneen R, Miller A, Solomon T. Acute central nervous system infections in adults--a retrospective cohort study in the NHS north west region. QJM. 2010;103(10):749–58.CrossRefPubMed
2.
go back to reference Logan SA, MacMahon E. Viral meningitis. BMJ (Clinical research ed). 2008;336(7634):36–40.CrossRef Logan SA, MacMahon E. Viral meningitis. BMJ (Clinical research ed). 2008;336(7634):36–40.CrossRef
4.
go back to reference Mandell LG, Bennett EJ, Raphael D: Principles and practice of infectious diseases. , vol. 1, 7 Philidelphia: Elsevier; 2010. Mandell LG, Bennett EJ, Raphael D: Principles and practice of infectious diseases. , vol. 1, 7 Philidelphia: Elsevier; 2010.
5.
6.
go back to reference Zunt JR, Baldwin KJ. Chronic and subacute meningitis. Continuum (Minneapolis, Minn). 2012;18(6 Infectious Disease):1290–318. Zunt JR, Baldwin KJ. Chronic and subacute meningitis. Continuum (Minneapolis, Minn). 2012;18(6 Infectious Disease):1290–318.
7.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed
8.
go back to reference Tumani H, Jobs C, Brettschneider J, Hoppner AC, Kerling F, Fauser S. Effect of epileptic seizures on the cerebrospinal fluid--a systematic retrospective analysis. Epilepsy Res. 2015;114:23–31.CrossRefPubMed Tumani H, Jobs C, Brettschneider J, Hoppner AC, Kerling F, Fauser S. Effect of epileptic seizures on the cerebrospinal fluid--a systematic retrospective analysis. Epilepsy Res. 2015;114:23–31.CrossRefPubMed
9.
go back to reference Gradel KO, Nielsen SL, Pedersen C, Knudsen JD, Ostergaard C, Arpi M, Jensen TG, Kolmos HJ, Sogaard M, Lassen AT, et al. Low completeness of bacteraemia registration in the Danish National Patient Registry. PLoS One. 2015;10(6):e0131682.CrossRefPubMedPubMedCentral Gradel KO, Nielsen SL, Pedersen C, Knudsen JD, Ostergaard C, Arpi M, Jensen TG, Kolmos HJ, Sogaard M, Lassen AT, et al. Low completeness of bacteraemia registration in the Danish National Patient Registry. PLoS One. 2015;10(6):e0131682.CrossRefPubMedPubMedCentral
10.
go back to reference Henriksen DP, Nielsen SL, Laursen CB, Hallas J, Pedersen C, Lassen AT. How well do discharge diagnoses identify hospitalised patients with community-acquired infections?--a validation study. PLoS One. 2014;9(3):e92891.CrossRefPubMedPubMedCentral Henriksen DP, Nielsen SL, Laursen CB, Hallas J, Pedersen C, Lassen AT. How well do discharge diagnoses identify hospitalised patients with community-acquired infections?--a validation study. PLoS One. 2014;9(3):e92891.CrossRefPubMedPubMedCentral
11.
go back to reference Segal BM. Neurosarcoidosis: diagnostic approaches and therapeutic strategies. Curr Opin Neurol. 2013;26(3):307–13.CrossRefPubMed Segal BM. Neurosarcoidosis: diagnostic approaches and therapeutic strategies. Curr Opin Neurol. 2013;26(3):307–13.CrossRefPubMed
12.
go back to reference Lo Monaco A, La Corte R, Caniatti L, Borrelli M, Trotta F. Neurological involvement in north Italian patients with Behcet disease. Rheumatol Int. 2006;26(12):1113–9.CrossRefPubMed Lo Monaco A, La Corte R, Caniatti L, Borrelli M, Trotta F. Neurological involvement in north Italian patients with Behcet disease. Rheumatol Int. 2006;26(12):1113–9.CrossRefPubMed
13.
go back to reference Kawai M, Hirohata S. Cerebrospinal fluid beta(2)-microglobulin in neuro-Behcet’s syndrome. J Neurol Sci. 2000;179(S 1–2):132–9.CrossRefPubMed Kawai M, Hirohata S. Cerebrospinal fluid beta(2)-microglobulin in neuro-Behcet’s syndrome. J Neurol Sci. 2000;179(S 1–2):132–9.CrossRefPubMed
15.
go back to reference Bremell D, Hagberg L. Clinical characteristics and cerebrospinal fluid parameters in patients with peripheral facial palsy caused by Lyme neuroborreliosis compared with facial palsy of unknown origin (Bell’s palsy). BMC Infect Dis. 2011;11:215.CrossRefPubMedPubMedCentral Bremell D, Hagberg L. Clinical characteristics and cerebrospinal fluid parameters in patients with peripheral facial palsy caused by Lyme neuroborreliosis compared with facial palsy of unknown origin (Bell’s palsy). BMC Infect Dis. 2011;11:215.CrossRefPubMedPubMedCentral
16.
go back to reference Chamberlain MC, Glantz MJ. Cerebrospinal fluid-disseminated meningioma. Cancer. 2005;103(7):1427–30.CrossRefPubMed Chamberlain MC, Glantz MJ. Cerebrospinal fluid-disseminated meningioma. Cancer. 2005;103(7):1427–30.CrossRefPubMed
Metadata
Title
Cerebrospinal fluid pleocytosis level as a diagnostic predictor? A cross-sectional study
Authors
Anne Ahrens Østergaard
Thomas Vognbjerg Sydenham
Mads Nybo
Åse Bengård Andersen
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Clinical Pathology / Issue 1/2017
Electronic ISSN: 1472-6890
DOI
https://doi.org/10.1186/s12907-017-0053-0

Other articles of this Issue 1/2017

BMC Clinical Pathology 1/2017 Go to the issue